Finally, instead of increasing the circulating number of neutrophils, the option to medically treat neutropenia by inflammatory cytokines, such as interferon γ and tumor necrosis factor α, yields a modulation of the immune response by the stimulation and activation of neutrophils in blood (41, 44). The gene discussed is TNF; the disease is neutropenia.